Amprius Technologies (NYSE:AMPX) Announces Earnings Results

Amprius Technologies (NYSE:AMPXGet Free Report) released its earnings results on Wednesday. The company reported ($0.01) EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.03, FiscalAI reports. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 25.77%. The firm had revenue of $25.23 million during the quarter, compared to analyst estimates of $22.91 million. Amprius Technologies updated its FY 2026 guidance to –0.060 EPS.

Amprius Technologies Stock Performance

AMPX stock traded up $1.75 during mid-day trading on Friday, hitting $16.64. 6,702,876 shares of the company were exchanged, compared to its average volume of 8,507,812. Amprius Technologies has a 1-year low of $1.70 and a 1-year high of $16.67. The firm’s 50 day simple moving average is $10.71 and its 200 day simple moving average is $10.63. The firm has a market cap of $2.17 billion, a P/E ratio of -48.94 and a beta of 3.04.

Insiders Place Their Bets

In other news, Director Kang Sun sold 61,251 shares of the business’s stock in a transaction dated Monday, February 23rd. The stock was sold at an average price of $10.16, for a total value of $622,310.16. Following the sale, the director directly owned 1,342,400 shares in the company, valued at $13,638,784. The trade was a 4.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CTO Constantin Ionel Stefan sold 25,366 shares of the stock in a transaction dated Monday, February 23rd. The stock was sold at an average price of $10.16, for a total value of $257,718.56. Following the transaction, the chief technology officer owned 723,330 shares of the company’s stock, valued at approximately $7,349,032.80. The trade was a 3.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 2,392,269 shares of company stock worth $26,384,359. 12.90% of the stock is currently owned by company insiders.

Institutional Trading of Amprius Technologies

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Bank of America Corp DE grew its position in Amprius Technologies by 31.1% in the fourth quarter. Bank of America Corp DE now owns 12,890 shares of the company’s stock valued at $36,000 after purchasing an additional 3,055 shares in the last quarter. AQR Capital Management LLC grew its holdings in shares of Amprius Technologies by 86.7% in the 1st quarter. AQR Capital Management LLC now owns 77,764 shares of the company’s stock valued at $208,000 after acquiring an additional 36,116 shares in the last quarter. Millennium Management LLC raised its holdings in Amprius Technologies by 94.5% during the first quarter. Millennium Management LLC now owns 1,396,013 shares of the company’s stock worth $3,741,000 after acquiring an additional 678,442 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in Amprius Technologies by 128.6% during the first quarter. Goldman Sachs Group Inc. now owns 244,646 shares of the company’s stock valued at $656,000 after purchasing an additional 137,640 shares during the last quarter. Finally, Rhumbline Advisers grew its stake in Amprius Technologies by 61.1% in the first quarter. Rhumbline Advisers now owns 15,690 shares of the company’s stock valued at $42,000 after purchasing an additional 5,951 shares in the last quarter. 5.04% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have weighed in on AMPX. Needham & Company LLC initiated coverage on Amprius Technologies in a research note on Thursday, January 29th. They issued a “buy” rating and a $20.00 target price on the stock. Oppenheimer reaffirmed an “outperform” rating and issued a $17.00 price target on shares of Amprius Technologies in a research note on Tuesday, December 23rd. Weiss Ratings reissued a “sell (e+)” rating on shares of Amprius Technologies in a research note on Wednesday, January 21st. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $20.00 target price on shares of Amprius Technologies in a research note on Friday. Finally, Craig Hallum initiated coverage on shares of Amprius Technologies in a report on Monday, February 23rd. They issued a “buy” rating and a $17.00 target price on the stock. Eight analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $17.13.

Check Out Our Latest Report on AMPX

Amprius Technologies News Summary

Here are the key news stories impacting Amprius Technologies this week:

About Amprius Technologies

(Get Free Report)

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

See Also

Earnings History for Amprius Technologies (NYSE:AMPX)

Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.